Skip to main content
. 2022 Feb 14;44(3):336–348. doi: 10.1590/2175-8239-JBN-2021-0194

Table 1. Comparison of sociodemographic and clinical variables in patients with altered vs. normal MoCA.

Variable MoCA altered MoCA normal p
Age (mean; sd) 58.2 ± 6.9 54.2 ± 9.2 0.06
Sex (%) Male 55.2 55.6 0.59
Female 44.8 44.4
Color (%) White 41.4 50.0 0.68
Black 24.1 15.4
Brown 34.5 34.6
Marital status (%) Married (stable union) 55.1 63.0 0.42
Divorced/Separated 24.1 7.4
Single 6.9 14.8
Widow(er) 13.8 14.8
Schooling Mean; sd 52.2 ± 2.8 6.8 ± 2.8 0.04
≥ 4 years (%) 82.8 96.2 0.12
< 4 years (%) 17.2 3.8
Income (MW) (%) Up to 2 60.0 50.0 0.82
2-4 33.3 38.9
> 4 6.7 11.1
BMI (%) 29.9 ± 4.7 31.2 ± 5.0 0.37
MBP (mean; sd) 143.7 ± 25.1 147.1 ± 23.1 0.62
DBP (mean; sd) 87.3 ± 13.6 91.9 ± 15.3 0.27
Comorbidities (%) SAH 96.6 92.6 0.60
DM 65.5 38.5 0.06
CVD 36.0 39.1 0.52
Depression (Mini Plus) 20.7 22.2 0.88
Hypothyroidism 16.0 18.2 0.57
Smoking 23.1 18.5 0.74
Drinking 4.0 14.8 0.35
Sedentarism 22.2 30.4 0.36
CKD category (%) 1 3.4 11.5 0.76
2 6.9 7.7
3A 27.6 15.4
3B 34.5 42.3
4 24.1 19.2
5 3.4 3.8
Medications being used (%) Opiates 0 0
Anti-parkinsonians 0 3.8 0.43
Hypnotics 3.6 0 0.52
Antiepileptics 14.3 20.0 0.71
Benzodiazepines 17.9 20.0 0.84
Antidepressants 38.5 45.5 0.77
ACEI 53.8 45.5 0.77
ARB 65.5 46.2 0.12
Betablockers 51.7 50.0 0.55
Adren. blockers 10.7 19.2 0.31
Vasodilators 3.4 3.8 0.72
Calcium Chanel blockers 34.5 46.2 0.27
Diuretics 92.3 68.2 0.04
Statins 57.7 54.5 0.52
Vitamin D 15.4 13.6 0.6
Oral hypoglycemics 73.1 31.8 0.008
Insulin 27.6 15.4 0.22
Erythropoietin 3.8 0 0.54
Iron 0 4.5 0.45
Levothyroxine 7.7 9.1 0.86
Nitrate 3.4 3.8 0.72
ASA 75.9 34.6 0.002

SD (±): Standard Deviation; %: percentage; ≥: greater than or equal to; <: less then; MW: minimum wage; BMI: body mass index; SAP: systolic arterial pressure; DAP: diastolic arterial pressure; SAH: Systemic Arterial Hypertension; DM: diabetes mellitus; CVD: cardiovascular disease; CKD: chronic kidney disease; ACEI: angiotensin converting enzyme inhibitor; ARB: angiotensin receptor blockers; ASA: acetyl-salicylic acid.